Redhill Biopharma
RDHL
#11160
Rank
A$3.77 M
Marketcap
A$0.42
Share price
-13.08%
Change (1 day)
-73.67%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): A-$1,010

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is A-$1,058. In 2017 the company made an earnings per share (EPS) of A-$3,777 a decrease over its 2016 EPS that were of A-$3,324.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$1,010
2017A-$3,77713.64%
2016A-$3,3249.12%
2015A-$3,04668.01%
2014A-$1,813-25.93%
2013A-$2,447

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.99-100.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$1.50-100.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.35-100.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.68-100.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
A$1.84-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel